Klaire Labs   Report issue

For profit Phase 3
Founded: Reno NV United States (1969)
Status: No NME R&D (1969)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (3)

Key: Klaire Labs (0) Acquired (3)

boswellia serrata (1 trial)

celery seed (1 trial)

phellodendron extract (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 1
  • # of Trial APIs: 3